Speaking at a webinar in July 2021, Gül Dölen, Associate Professor of Neuroscience at The Johns Hopkins University, presented her research into the therapeutic effects and the mechanism of action of MDMA.
Speaking at an Analytical Cannabis webinar in January 2022, Kim Ross, PhD, Chief Science Officer at Peak Compliance LLC, presented her talk on hemp regulation, testing and standardization.
Speaking at a webinar in March 2021, Alisia Ratliff, CEO of Victus Capital Ventures, presented the history of extraction and methodologies as well as what the future holds.
Speaking at a webinar in February 2021, Chris Tasker, Chief Executive Officer of Global Cannabinoid Solutions presented about current UK cannabis legislation and proposed law improvements within the UK.
Speaking at a webinar in March 2021, Cosmo Feilding-Mellen, Co-Founder & Chief Executive of Beckley Psytech, explored the promising medical qualities of psychedelics, such as LSD and psilocybin “magic” mushrooms
Speaking at a webinar in February 2021, Dr Natalia Sannikova, Research & Development Manager and Tomas Skrinskas, Founder & CEO from Ascension Sciences presented their research of cannabinoid nanoparticles.
Latent lead from cannabis vape hardware is more common than expected and is missed by some state and national testing protocols. We present a survey of results outlining the extent of the problem and how gaps in quality and testing systems can lead to latent lead exposure. We recommend a combination of testing protocols, supplier quality management, and consumer transparency to drive the lead out of the vape hardware supply chain.